For research use only. Not for therapeutic Use.
Levofloxacin N-oxide (CAT: C000246) is a byproduct or impurity that can arise during the synthesis or degradation of Ofloxacin, a fluorinated quinolone antibacterial agent. Ofloxacin is widely used to treat various bacterial infections. Levofloxacin N-oxide may be formed when Ofloxacin undergoes oxidation or other chemical transformations. While it is not the primary active component, the presence of impurities like Levofloxacin N-oxide is carefully monitored in pharmaceutical formulations to ensure the purity, safety, and efficacy of the final product.
| Catalog Number | C000246 |
| CAS Number | 117678-38-3 |
| Synonyms | (3S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-4-oxido-1-piperazinyl)-7-oxo-7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid; (S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic Acid N-oxide |
| Molecular Formula | C₁₈H₂₀FN₃O₅ |
| Purity | ≥95% |
| Target | Drug Metabolite |
| Solubility | Aqueous Base (Slightly), DMSO (Slightly), Methanol (Slightly) |
| Appearance | Off-White to Pale Green Solid |
| Storage | -20°C, Hygroscopic |
| Reference | Horstkotter, C., et al.: J. Chromatography Biomed. Sci. Appli., 754, 169 (2001); Monk, J.P., et al.: Drugs, 33, 346 (1987), Drlica, K., Curr. Opin. Microbiol. 2, 504 (1990) |
